The burden of primary diseases is substantial, demanding groundbreaking therapeutic options. Cellular therapies represent a particularly promising avenue, offering the potential to regenerate damaged parenchymal tissue and alleviate patient outcomes. Currently, research focuses on several methods, including the administration of adult cellular enti